Your browser doesn't support javascript.
loading
The EGFR/ErbB inhibitor neratinib modifies the neutrophil phosphoproteome and promotes apoptosis and clearance by airway macrophages.
Herman, Kimberly D; Wright, Carl G; Marriott, Helen M; McCaughran, Sam C; Bowden, Kieran A; Collins, Mark O; Renshaw, Stephen A; Prince, Lynne R.
Afiliação
  • Herman KD; Department of Infection, Immunity and Cardiovascular Disease, The Medical School, University of Sheffield, Sheffield, United Kingdom.
  • Wright CG; Department of Infection, Immunity and Cardiovascular Disease and The Bateson Centre, The Medical School, University of Sheffield, Sheffield, United Kingdom.
  • Marriott HM; Department of Infection, Immunity and Cardiovascular Disease, The Medical School, University of Sheffield, Sheffield, United Kingdom.
  • McCaughran SC; Department of Infection, Immunity and Cardiovascular Disease, The Medical School, University of Sheffield, Sheffield, United Kingdom.
  • Bowden KA; Department of Infection, Immunity and Cardiovascular Disease, The Medical School, University of Sheffield, Sheffield, United Kingdom.
  • Collins MO; Department of Infection, Immunity and Cardiovascular Disease, The Medical School, University of Sheffield, Sheffield, United Kingdom.
  • Renshaw SA; Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom.
  • Prince LR; Department of Infection, Immunity and Cardiovascular Disease, The Medical School, University of Sheffield, Sheffield, United Kingdom.
Front Immunol ; 13: 956991, 2022.
Article em En | MEDLINE | ID: mdl-35967296

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peixe-Zebra / Neutrófilos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peixe-Zebra / Neutrófilos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido